Quantifying mRNA in postmortem human brain: Influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance

Molecular Brain Research

Volumn 118, Issue 1-2, 2003, Pages 60-71

  Preece, Paul ^a   Cairns, Nigel J ^b  

^a Seixo Branco   (Spain)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer's disease; Confounding factors; Human brain; mRNA; Quantification; TaqMan

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BETA ACTIN; CYCLOPHILIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; NEURON SPECIFIC ENOLASE;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN CORTEX; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PH; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SEX DIFFERENCE;

EID: 0141957335     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(03)00337-1     Document Type: Article

References (22)

1. Altschul S., Gish W., Miller W., Myers E., Lipman D. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
2. Barton A.J., Pearson R.C., Najlerahim A., Harrison P.J. Pre- and postmortem influences on brain RNA. J. Neurochem. 61:1993;1-11.
3. Bond B.C., Virley D.J., Cairns N.J., Moore G., Moss S.J., Mudge A.W., Walsh F.W., Jazin E., Preece P. The quantification of gene expression in an animal model of brain ischaemia using TaqMan real-time RT-PCR. Mol. Brain Res. 106:2002;101-116.
4. Preece P., Virley D.J., Constandi M., Coombes R., Moss S.J., Mudge A.W., Jazin E., Cairns N.J. An optimistic view for quantifying mRNA in post-mortem human brain. Mol. Brain Res. 116:2003;7-16.
5. Clark A.W., Tran P.M., Parhad I.M., Krekoski C.A., Julien J.P. Neuronal gene expression in amyotrophic lateral sclerosis. Mol. Brain Res. 7:1990;75-83.
6. Cochran W.G., Cox G.M. Experimental Designs. 2nd ed. 1957;Wiley, New York.
7. Gibson U.E., Heid C.A., Williams P.M. A novel method for real time quantitative RT-PCR. Genome Res. 6:1996;995-1001.
8. Hardy J.A., Wester P., Winblad B., Gezelius C., Bring G., Eriksson A. The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue. J. Neural Transm. 61:1985;253-264.
9. Harrison P.J., Procter A.W., Barton A.J.L., Lowe S.L., Najlerahim A., Bertolucci P.H.F., Bowen D.M., Pearson R.C.A. Terminal coma affects messenger RNA detection in postmortem human temporal cortex. Mol. Brain Res. 9:1991;161-164.
10. Harrison P.J., Barton A.J., Procter A.W., Bowen D.M., Pearson R.C. The effects of Alzheimer's disease, other dementias, and premortem course on beta-amyloid precursor protein messenger RNA in frontal cortex. J. Neurochem. 62:1994;635-644.
11. Harrison P.J., Heath P.R., Eastwood S.L., Burnet P.W., McDonald B., Pearson R.C. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci. Lett. 200:1995;151-154.
12. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 6:1996;986-994.
13. Hulette C., Mirra S., Wilkinson W., Heyman A., Fillenbaum G., Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease. Neurology. 45:1995;1991-1995.
14. Johnston N.L., Cervenak J., Shore A.D., Torrey E.F., Yolken R.H., Cerevnak J. Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. J. Neurosci. Methods. 77:1997;83-92.
15. Kingsbury A.E., Foster O.J., Nisbet A.P., Cairns N., Bray L., Eve D.J., Lees A.J., Marsden C.D. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Mol. Brain Res. 28:1995;311-318.
16. Lie Y.S., Petropoulos C.J. Advances in quantitative PCR technology: 5′ nuclease assays. Curr. Opin. Biotechnol. 9:1998;43-48.
17. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
18. Mirnics K., Middleton F., Marquez A., Lewis D.A., Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 28:2000;53-67.
19. Perry E.K., Perry R.H. Human brain neurochemistry - some postmortem problems. Life Sci. 33:1983;1733-1743.
20. Ross B.M., Knowler J.T., McCulloch J. On the stability of messenger RNA and ribosomal RNA in the brains of control human subjects and patients with Alzheimer's disease. J. Neurochem. 58:1992;1810-1819.
21. Spanakis E. Problems related to the interpretation of autoradiographic data on gene expression using common constitutive transcripts as controls. Nucleic Acids Res. 21:1993;3809-3819.
22. Spanakis E., Brouty-Boye D. Evaluation of quantitative variation in gene expression. Nucleic Acids Res. 22:1994;799-806.